Amantadine and rimantadine for influenza A in children and the elderly (Q24187883)

title

Amantadine and rimantadine for influenza A in children and the elderly (English)

0 references

author name string

Márcia G Alves Galvão

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marilene Augusta Rocha Crispino Santos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Antonio J L Alves da Cunha

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

9 June 2020

publication date

21 November 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

CD002745

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population.

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral therapy and prophylaxis for influenza in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

The use of antiviral drugs for influenza: recommended guidelines for practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Influenza in immunocompromised patients: considerations for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine kinetics in healthy elderly men: implications for influenza prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Safety and pharmacokinetics of rimantadine small-particle aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine and interferon in the combined treatment of hepatitis C virus in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Drugs in development for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Chinese medicinal herbs for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Medical treatment of viral pneumonia including SARS in immunocompetent adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Assessing the quality of evidence from randomized, controlled drug and nutritional supplement trials conducted among nursing home residents between 1968 and 2004: what can we learn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Two years after pandemic influenza A/2009/H1N1: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Comparing patient access to pharmaceuticals in the UK and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Influenza prophylaxis in the long-term care facility: a case-control study of the risk factors for adverse drug reactions to amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Health outcomes among patients receiving oseltamivir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Treatment options for 2009 H1N1 influenza: evaluation of the published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral effects of Glycyrrhiza species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Mechanism of action of T-705 against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Complementary medicine for treating or preventing influenza or influenza-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Molecular basis of resistance of influenza A viruses to amantadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine aerosols in normal volunteers: pharmacology and safety testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Comparative therapeutic effect of aerosolized and oral rimantadine HCl in experimental human influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Experimental human influenza: observations from studies of influenza antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antivirals and the control of influenza outbreaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Clinical use of approved influenza antivirals: therapy and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Evaluation of influenza vaccination in health-care workers, using rapid antigen detection test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antivirals for influenza in healthy adults: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Chinese medicinal herbs for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

NMDA receptors in clinical neurology: excitatory times ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Methodological considerations for future controlled influenza treatment trials in complementary and alternative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Ribavirin small-particle aerosol treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Sustained-release fampridine for symptomatic treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

A Randomized, Controlled Study of Kan Jang versus Amantadine in the Treatment of Influenza in Volgograd

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantidine hydrochloride and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the De

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Neurologic manifestations in children with influenza B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Influenza (H5N1) viruses in poultry, Russian Federation, 2005-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral agents for influenza: a comparison of cost-effectiveness data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Use of Oseltamivir to control influenza complications after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Characterization of H9N2 influenza A viruses isolated from chicken products imported into Japan from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Neuraminidase inhibitors for preventing and treating influenza in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Peginterferon alfa-2a: a review of approved and investigational uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Proton transport through influenza A virus M2 protein reconstituted in vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Prevention of Russian Influenza by Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Prevention of nosocomial influenza infection with Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Protection of Man from Natural Infection with Influenza A2 Hong Kong Virus by Amantadine: A Controlled Field Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

John F. Enders lecture 2006: antivirals for influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Re-emergence of fatal human influenza A subtype H5N1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Successful treatment of juvenile chronic arthritis with a specific antiviral agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Modulation of human motor cortex excitability by single doses of amantadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Management of influenza symptoms in healthy children: cost-effectiveness of rapid testing and antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

An off-seasonal amantadine-resistant H3N2 influenza outbreak in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Pardoprunox in early Parkinson's disease: results from 2 large, randomized double-blind trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral therapy for influenza : a clinical and economic comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Effect of a plant polyphenol-rich extract on the lung protease activities of influenza-virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Evaluation of amantadine in artificially induced A2 and B influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Economic consequence of immediate testing for C-reactive protein and leukocyte count in new outpatients with acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Evaluation of Therapeutic Efficacy of Amantadine in Patients With Naturally Occurring A2 Influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Cyclooctylamine in the prevention of experimental human influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Combating influenza with antiviral therapy in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Preventing influenza: an overview of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Trial of amantadine in epidemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

The role of oseltamivir in the treatment and prevention of influenza in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Avian influenza virus infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral treatment and prophylaxis of influenza in primary care: German recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Investigation of the Reconsultation Rate and Pharmacoeconomic Evaluation of Period of Influenza Treatment by Oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antibiotics for acute maxillary sinusitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Burden of paediatric influenza in Western Europe: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

New treatments for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Viral infection of the lungs through the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Spared an influenza pandemic for another year?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Prevention and early treatment of influenza in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Vaccines for preventing influenza in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Influenza--interpandemic as well as pandemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Understanding the symptoms of the common cold and influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Pandemic influenza: is an antiviral response realistic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Antiviral resistance in influenza viruses--implications for management and pandemic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine and rimantadine for influenza A in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Vaccines for preventing influenza in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Neuraminidase inhibitors for preventing and treating influenza in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Epidemiology of human infections with avian influenza A(H7N9) virus in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Adapting global influenza management strategies to address emerging viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

R292K substitution and drug susceptibility of influenza A(H7N9) viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Interventions to increase influenza vaccination rates of those 60 years and older in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Influenza: diagnosis, management, and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Interventions for treating influenza: an overview of Cochrane systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine and rimantadine for influenza A in children and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Amantadine and rimantadine for influenza A in children and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB4

Airway hyperreactivity and peripheral airway dysfunction in influenza A infection

21 January 2018

1 reference

12 December 2020

Administration of amantadine for the prevention of Hong Kong influenza

1 reference

12 December 2020

Influenza infection and COPD.

1 reference

12 December 2020

Evaluation of amantadine hydrochloride in the treatment of A2 influenzal disease.

1 reference

12 December 2020

Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza A infection

1 reference

12 December 2020

Antiviral treatment of influenza in humans

1 reference

12 December 2020

A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness

1 reference

12 December 2020

Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A

1 reference

12 December 2020

Amantadine hydrochloride as a prophylactic in respiratory infections. A double-blind investigation of its clinical use and serology

1 reference

12 December 2020

Influenza prevention with 1-amino-adamantan-hydrochloride. II

1 reference

12 December 2020

Effect of inosiplex (Isoprinosine®) on induced human influenza A infection

1 reference

12 December 2020

Clinical features of influenza.

1 reference

12 December 2020

Antivirals and antibiotics for influenza in the United States, 1995--2002

1 reference

12 December 2020

Prophylactic use of amantadine during Hong Kong influenza epidemic.

1 reference

12 December 2020

Extracorporeal life support for pandemic influenza: the role of extracorporeal membrane oxygenation in pandemic management.

1 reference

12 December 2020

Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.

1 reference

12 December 2020

Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Serological diagnosis of influenza A/USSR/77 H1N1 infection: value of ELISA compared to other antibody techniques

1 reference

12 December 2020

Early diagnosis and treatment of influenza

1 reference

12 December 2020

Amantadine therapy of epidemic influenza a(2) (Hong Kong)

1 reference

12 December 2020

Effectiveness of midantan and interferon inducers as means of non-specific prevention of influenza

1 reference

12 December 2020

[Chemotherapeutics for treatment of influenza and other viral respiratory tract infections in children]

1 reference

12 December 2020

Use of Viregyt (amantadine hydrochloride) in the treatment of epidemic influenza

1 reference

12 December 2020

A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children

1 reference

12 December 2020

The therapeutic efficacy of Symmetrel (amantadine hydrochloride) in naturally occurring influenza A2 respiratoy illness

1 reference

12 December 2020

A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic

1 reference

12 December 2020

Multiple sclerosis in children

1 reference

12 December 2020

Therapeutic effectiveness of amantadine hydrochloride in naturally occurring Hong Kong influenza--double-blind studies

1 reference

12 December 2020

Therapeutic efficacy of amantadine hydrochloride in patients with epidemic influenza A virus infection

1 reference

12 December 2020

Epidemiology of influenza

1 reference

12 December 2020

[Prevention of influenza A. Effectiveness and tolerance of rimantadine hydrochloride]

1 reference

12 December 2020

Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983

1 reference

12 December 2020

Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis

1 reference

12 December 2020

Effectiveness of rimantadine prophylaxis of children within families

1 reference

12 December 2020

Children with influenza A infection: treatment with rimantadine.

1 reference

12 December 2020

Therapeutic effectiveness of amantadine hydrochloride in influenza A2--double blind studies

1 reference

12 December 2020

[Recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics: influenza vaccination campaign 2006-2007]

1 reference

12 December 2020

Comparison of pharmacokinetic and safety profiles of amantadine 50- and 100-mg daily doses in elderly nursing home residents

1 reference

12 December 2020

A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd

1 reference

12 December 2020

Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adults

1 reference

12 December 2020

Neuraminidase inhibitors for influenza treatment and prevention in healthy adults.

1 reference

12 December 2020

[Comparative study of the epidemiological efficacy of specific and nonspecific influenza preventive agents]

1 reference

12 December 2020

The prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C

1 reference

12 December 2020

Successful treatment of naturally occurring influenza A/USSR/77 H1N1.

1 reference

12 December 2020

Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols

1 reference

12 December 2020

Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment

1 reference

12 December 2020

Low incidence of rimantadine resistance in field isolates of influenza A viruses

1 reference

12 December 2020

Antiviral drugs in influenza: an adjunct to vaccination in some situations

1 reference

12 December 2020

Human infection by avian influenza A H5N1.

1 reference

12 December 2020

Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A

1 reference

12 December 2020

Use of rimantadine in familial foci during an epidemic of influenza caused by A1 virus

1 reference

12 December 2020

Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

1 reference

12 December 2020

Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A

1 reference

12 December 2020

Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates

1 reference

12 December 2020

Management of respiratory viral infections in hematopoietic cell transplant recipients

1 reference

12 December 2020

Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.

1 reference

12 December 2020

Influenza A prophylaxis with amantadine in a boarding school

1 reference

12 December 2020

Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans

1 reference

12 December 2020

Effect of rimantadine on the immune response to influenza A infections

1 reference

12 December 2020

Are neuraminidase inhibitors effective for preventing and treating influenza in healthy adults and children?

1 reference

12 December 2020

Seasonal and pandemic influenza: recommendations for preparedness in the United States

1 reference

12 December 2020

Prevention of influenza A/USSR/77 (H1N1): an evaluation of the side effects and efficacy of amantadine in recruits at Fort Sam Houston

1 reference

12 December 2020

Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza

1 reference

12 December 2020

Influenza a (H1N1) outbreak and challenges for pharmacotherapy.

1 reference

12 December 2020

Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best

1 reference

12 December 2020

Remantadine in the treatment of influenza in children

1 reference

12 December 2020

Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis

1 reference

12 December 2020

Antiviral activity of rimantadine, virological, pathomorphological, and clinical studies

1 reference

12 December 2020

A design for the evaluation of antiviral drugs in human influenza

1 reference

12 December 2020

Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak

1 reference

12 December 2020

The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine

1 reference

12 December 2020

Rimantadine prophylaxis in children: a follow-up study

1 reference

12 December 2020

Amantadine therapy of epidemic influenza A2-Hong Kong

1 reference

12 December 2020

The therapeutic effect of amantadine in influenza occurring during the winter of 1971-2 assessed by double-blind study

1 reference

12 December 2020

10.1002/14651858.CD002745.PUB4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25415374%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference